Industry NewsCBD, the latest wellness craze, won’t cause users to fail a drug test—but its lesser known cousin CBN will
Industry NewsEisai's Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China
Product NewsNovel Raw Materials Program Solves Regulatory Compliance Challenges in Small Molecule Drug Manufacturing